Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Contingently Issuable Common Stock (Details)

v3.24.0.1
Summary of Significant Accounting Policies - Contingently Issuable Common Stock (Details)
12 Months Ended
Dec. 31, 2023
d
$ / shares
shares
Dec. 31, 2022
$ / shares
Business Acquisition, Contingent Consideration [Line Items]    
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Unvested restricted stock units    
Business Acquisition, Contingent Consideration [Line Items]    
Vesting period 3 years  
Share-based Payment Arrangement, Tranche Two    
Business Acquisition, Contingent Consideration [Line Items]    
Number of trading days | d 20  
Number of consecutive trading days | d 30  
Share-based Payment Arrangement, Tranche Two | Maximum    
Business Acquisition, Contingent Consideration [Line Items]    
Vesting period 5 years  
Share-based Payment Arrangement, Tranche Two | Minimum    
Business Acquisition, Contingent Consideration [Line Items]    
Share price (in dollars per share) | $ / shares $ 12.50  
Share-based Payment Arrangement, Tranche Three    
Business Acquisition, Contingent Consideration [Line Items]    
Vesting period 5 years  
Number of trading days | d 20  
Number of consecutive trading days | d 30  
Share-based Payment Arrangement, Tranche Three | Minimum    
Business Acquisition, Contingent Consideration [Line Items]    
Share price (in dollars per share) | $ / shares $ 15.00  
Common Class B | Share-based Payment Arrangement, Tranche One    
Business Acquisition, Contingent Consideration [Line Items]    
Shares vested (in shares) 1,897,500  
Common Class B | Share-based Payment Arrangement, Tranche Two    
Business Acquisition, Contingent Consideration [Line Items]    
Shares vested (in shares) 948,750  
Common Class B | Share-based Payment Arrangement, Tranche Three    
Business Acquisition, Contingent Consideration [Line Items]    
Shares vested (in shares) 948,750  
Stock options    
Business Acquisition, Contingent Consideration [Line Items]    
Vesting period 4 years  
Give Evolv LLC    
Business Acquisition, Contingent Consideration [Line Items]    
Remaining number of founder shares 517,500  
NHIC Sub Inc    
Business Acquisition, Contingent Consideration [Line Items]    
Shares outstanding (in shares) 4,312,500  
Common stock, par value (in dollars per share) | $ / shares $ 0.0001